| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
9 companies
Armistice Capital, LLC serves as a 10% Owner at HIND and has filed Form 4s across 9 companies. Across recent SEC filings that breaks down to 337 buys and 114 sells. Those positions are worth an estimated $10.1M at current prices.
Historically, Armistice Capital, LLC's trades have earned a middling insider score of 56/100 across 42 rated trades. Over a 12-month horizon, 23.8% of those trades were profitable, with an average 12-month return of -33.4%.
The biggest single holding is ACHV (~$3.7M) as 10% Owner. The recent filings there lean toward selling, a net 299,332 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2018 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 31,314 | $3.85 | $120,577.82 | +0.2% | |
| Oct 31, 2018 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 5,986 | $3.92 | $23,481.35 | - | |
| Oct 29, 2018 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 107,800 | $3.95 | $425,512.48 | +0.6% | |
| Oct 24, 2018 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 125,800 | $4.13 | $519,064.36 | +0.7% | |
| Oct 9, 2018 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 29,600 | $4.34 | $128,404.61 | +0.2% | |
| Oct 3, 2018 | SAVA Cassava Sciences Inc | 10% Owner | Sell | 512,660 | $1.31 | $671,738.40 | -100% | |
| Sep 27, 2018 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 20,400 | $4.64 | $94,628.59 | +0.1% | |
| Aug 20, 2018 | SAVA Cassava Sciences Inc | 10% Owner | Sell | 1,256,000 | $1.02 | $1,275,136.00 | -36.7% | |
| Aug 17, 2018 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 1,000,000 | $3.91 | $3,910,000.00 | +6.1% | |
| Jul 31, 2018 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 2,855 | $4.25 | $12,134.32 | - |